NewsRx

Search our medical news database

Vectors

Successful Transient Expression Delivered by Ad Vectors into Human Bone Marrow

Published in Gene Therapy Weekly, August 26th, 1996

Recombinant adenovirus (Ad) vectors transfer genes to human bone marrow (BM) hematopoietic cells at high transduction efficiencies.

Recombinant Ad vectors are capable of efficiently infecting a broad range of host cells, including both quiescent and dividing cells. Because the adenoviral DNA does not integrate into the host cell genome, this system permits transient expression of large amounts of gene products.

The hematopoietic system offers many benefits of transduction as it may be transduced ex vivo. The transient nature of Ad vectors actually could make them the vector of choice for some gene therapy protocols (e.g., induced expression of...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook